MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$704M
AUM Growth
+$37.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$18M
3
+$15.6M
4
CNTX icon
Context Therapeutics
CNTX
+$15.4M
5
REPL icon
Replimune Group
REPL
+$11.5M

Top Sells

1
+$15.6M
2
+$15.4M
3
+$10.4M
4
VKTX icon
Viking Therapeutics
VKTX
+$7.66M
5
NTLA icon
Intellia Therapeutics
NTLA
+$5.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-267,557
52
– –
-50,000
53
– –
-11,518
54
– –
-120,982
1 2
3